Any autoimmune condition | Medication cohort | Number of patientsa | Total f/u years | Number of visits | Autoimmune visits | Autoimmune visits per patient per f/u year | ||||
---|---|---|---|---|---|---|---|---|---|---|
Mean (SD) | 95% CI LB | 95% CI UB | Range | p-valueb | ||||||
All | Other non-C1-INH | 276 | 729 | 62,864 | 1528 | 2.3 (12.22) | 0.832 | 3.727 | 0–107.03 | 0.7369 |
pdC1-INH | 313 | 860 | 85,859 | 1381 | 1.4 (7.30) | 0.562 | 2.185 | 0–107.08 | ||
< 50 years | ||||||||||
Male | Other non-C1-INH | 56 | 136 | 6087 | 66 | 0.6 (3.21) | − 0.213 | 1.505 | 0–21.97 | 0.0733 |
pdC1-INH | 45 | 120 | 8082 | 0 | 0.0 (0.00) | 0.000 | 0.000 | 0.0000 | ||
Female | Other non-C1-INH | 110 | 286 | 29,465 | 1188 | 4.7 (18.69) | 1.178 | 8.243 | 0–107.03 | 0.6410 |
pdC1-INH | 146 | 386 | 44,613 | 1004 | 2.0 (9.79) | 0.381 | 3.583 | 0–107.08 | ||
Lupus | ||||||||||
All | Other non-C1-INH | 276 | 729 | 62,864 | 324 | 0.6 (6.92) | − 0.189 | 1.451 | 0–105.23 | 0.375 |
pdC1-INH | 313 | 860 | 85,885 | 357 | 0.4 (2.65) | 0.078 | 0.667 | 0–26.14 | ||
< 50 years | ||||||||||
Male | Other non-C1-INH | 56 | 136 | 6087 | 0 | 0.0 (0.00) | 0.000 | 0.000 | 0–0 | 1.0000 |
pdC1-INH | 45 | 120 | 8082 | 0 | 0.0 (0.00) | 0.000 | 0.000 | 0–0 | ||
Female | Other non-C1-INH | 110 | 286 | 29,465 | 315 | 1.6 (10.92) | − 0.499 | 3.629 | 0–105.23 | 0.6040 |
pdC1-INH | 146 | 386 | 44,613 | 236 | 0.5 (2.68) | 0.025 | 0.900 | 0–25.91 |